Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2019 11:43 ET | Source: Tusker Medical

Breakthrough In-Office Ear Tube Solution From Tusker Medical Receives FDA Approval

Tula System Offers ENTs, Patients and Parents an Option Without the Operating Room Menlo Park, CA, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tusker® Medical today announced United...
January 02, 2019 16:05 ET | Source: Otonomy, Inc.

Otonomy to Present at the J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
November 15, 2018 08:30 ET | Source: Otonomy, Inc.

Otonomy to Participate in Piper Jaffray 30th Annual Healthcare Conference

SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that David...
November 05, 2018 16:12 ET | Source: Otonomy, Inc.

Otonomy Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Conference call and webcast today at 4:30 p.m. EST Conference call will include review of OTO-413 program selected as "Hot Topic" at Society for Neuroscience Annual Meeting SAN DIEGO, Nov. 05, 2018...
February 24, 2017 07:30 ET | Source: Otonomy, Inc.

Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update

SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
August 04, 2016 16:09 ET | Source: Otonomy, Inc.

Otonomy Reports Second Quarter 2016 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
September 03, 2014 08:00 ET | Source: Otonomy, Inc.

Otonomy Announces Full Exercise of Underwriters' Option to Purchase Additional Shares

SAN DIEGO, Sept. 3, 2014 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...